723 related articles for article (PubMed ID: 12942184)
1. [Androgenetic alopecia. Current aspects of a common phenotype].
Hanneken S; Ritzmann S; Nöthen MM; Kruse R
Hautarzt; 2003 Aug; 54(8):703-12. PubMed ID: 12942184
[TBL] [Abstract][Full Text] [Related]
2. Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women.
Whiting DA; Waldstreicher J; Sanchez M; Kaufman KD
J Investig Dermatol Symp Proc; 1999 Dec; 4(3):282-4. PubMed ID: 10674382
[TBL] [Abstract][Full Text] [Related]
3. Androgenetic alopecia and current methods of treatment.
Bienová M; Kucerová R; Fiurásková M; Hajdúch M; Koláŕ Z
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):5-8. PubMed ID: 15818439
[TBL] [Abstract][Full Text] [Related]
4. Pattern hair loss in men: diagnosis and medical treatment.
Banka N; Bunagan MJ; Shapiro J
Dermatol Clin; 2013 Jan; 31(1):129-40. PubMed ID: 23159182
[TBL] [Abstract][Full Text] [Related]
5. A review of the treatment of male pattern hair loss.
York K; Meah N; Bhoyrul B; Sinclair R
Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
[No Abstract] [Full Text] [Related]
6. Androgenetic alopecia: pathogenesis and potential for therapy.
Ellis JA; Sinclair R; Harrap SB
Expert Rev Mol Med; 2002 Nov; 4(22):1-11. PubMed ID: 14585162
[TBL] [Abstract][Full Text] [Related]
7. Multi-therapies in androgenetic alopecia: review and clinical experiences.
Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
[TBL] [Abstract][Full Text] [Related]
8. Genetic and molecular aspects of androgenetic alopecia.
Martinez-Jacobo L; Villarreal-Villarreal CD; Ortiz-López R; Ocampo-Candiani J; Rojas-Martínez A
Indian J Dermatol Venereol Leprol; 2018; 84(3):263-268. PubMed ID: 29595184
[TBL] [Abstract][Full Text] [Related]
9. Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.
Sinclair R; Patel M; Dawson TL; Yazdabadi A; Yip L; Perez A; Rufaut NW
Br J Dermatol; 2011 Dec; 165 Suppl 3():12-8. PubMed ID: 22171680
[TBL] [Abstract][Full Text] [Related]
10. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of minoxidil in the treatment of androgenetic alopecia is likely mediated by mitochondrial adenosine triphosphate synthase-induced stem cell differentiation.
Goren A; Naccarato T; Situm M; Kovacevic M; Lotti T; McCoy J
J Biol Regul Homeost Agents; 2017; 31(4):1049-1053. PubMed ID: 29254313
[TBL] [Abstract][Full Text] [Related]
12. Treatments for androgenetic alopecia and alopecia areata: current options and future prospects.
Meidan VM; Touitou E
Drugs; 2001; 61(1):53-69. PubMed ID: 11217871
[TBL] [Abstract][Full Text] [Related]
13. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
Gassmueller J; Hoffmann R; Webster A
Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
[TBL] [Abstract][Full Text] [Related]
14. Male pattern baldness.
Hogan DJ; Chamberlain M
South Med J; 2000 Jul; 93(7):657-62. PubMed ID: 10923949
[TBL] [Abstract][Full Text] [Related]
15. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
Shanshanwal SJ; Dhurat RS
Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
Gupta AK; Mays RR; Dotzert MS; Versteeg SG; Shear NH; Piguet V
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2112-2125. PubMed ID: 29797431
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
Tanglertsampan C
J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia.
Whiting DA
J Am Acad Dermatol; 1993 May; 28(5 Pt 1):755-63. PubMed ID: 8496421
[TBL] [Abstract][Full Text] [Related]
19. [Diffuse hair loss in women].
Trüeb RM
Ther Umsch; 2002 May; 59(5):217-22. PubMed ID: 12090117
[TBL] [Abstract][Full Text] [Related]
20. The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years.
Barbareschi M
G Ital Dermatol Venereol; 2018 Feb; 153(1):102-106. PubMed ID: 29319278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
